{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:47:38Z","timestamp":1792597658128,"version":"4.5.0"},"reference-count":26,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec>\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Colorectal cancer (CRC) screening is suboptimal among people in traditionally underserved populations, many of whom receive primary care at federally qualified health centers (FQHCs). Mailed fecal immunochemical test (FIT) outreach improves screening, especially in underserved populations, but questions remain about impact over time.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the effectiveness of centralized annual mailed FIT outreach delivered over 3 years to increase CRC screening in FQHCs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This cluster randomized clinical trial was conducted between June 1, 2021, and May 31, 2024. Sixteen clinics from 2 FQHCs in Southern California were randomly assigned to mailed FIT outreach or usual care for patients aged 50 to 75 years and not up to date with screening.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Intervention<\/jats:title>\n                    <jats:p>Intervention components followed best practices for mailed FIT outreach and included educational primers, FIT kits, and telephone reminders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The primary outcome was the proportion of individuals up to date with any CRC screening after 3 years of intervention (point prevalence); screening at 2 years was a secondary outcome. Due to a resource constraint\u2013related protocol modification, mailed FIT outreach began earlier in year 3, such that some individuals who completed screening in year 2 were not yet due for repeat FIT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 16 clinics serving 20\u202f250 patients, 6 clinics serving 8334 individuals at baseline (4435 aged 55-64 years [53.2%]; 4896 female [58.7%]; 341 Asian [4.1%], 238 Black [2.9%], 2390 Hispanic [28.7%], and 4371 non-Hispanic White [52.4%]) were randomized to intervention and 10 clinics serving 11\u202f916 individuals at baseline (6443 aged 55-64 years [54.1%]; 7250 female [60.8%]; 699 Asian [5.9%], 355 Black [3.0%], 4635 Hispanic [38.9%], and 4436 non-Hispanic White [37.2%]) were randomized to usual care. At year 3, screening was 39.4% (95% CI, 36.3% to 42.6%) in intervention clinics vs 36.5% (95% CI, 31.2% to 42.2%) in usual care clinics, which was not a statistically significant difference (2.9 percentage points; 95% CI, \u22123.2 to 9.0 percentage points). At year 2, screening was 37.8% (95% CI, 35.2% to 40.4%) in intervention clinics vs 27.0% (95% CI, 21.8% to 32.9%) in usual care clinics (difference, 10.8 percentage points; 95% CI, 4.9 to 16.7 percentage points).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>This study\u2019s findings suggest that centralized mailed FIT outreach could increase CRC screening in FQHCs serving populations with persistent disparities, although maintaining intervention fidelity and providing ongoing implementation support over time are needed for consistent impact.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov Identifier:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/study\/NCT04941300\">NCT04941300<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.39013","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:00:42Z","timestamp":1792594842000},"page":"e2639013","source":"Crossref","is-referenced-by-count":0,"title":["Fecal Immunochemical Test Outreach for Colorectal Cancer Screening in Community Health Centers"],"prefix":"10.1001","volume":"9","author":[{"given":"Maria Elena","family":"Martinez","sequence":"first","affiliation":[{"name":"UC San Diego Moores Cancer Center, University of California San Diego, La Jolla"},{"name":"Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, La Jolla"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Roesch","sequence":"additional","affiliation":[{"name":"Department of Psychology, San Diego State University, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valesca","family":"Largaespada","sequence":"additional","affiliation":[{"name":"UC San Diego Moores Cancer Center, University of California San Diego, La Jolla"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse N.","family":"Nodora","sequence":"additional","affiliation":[{"name":"UC San Diego Moores Cancer Center, University of California San Diego, La Jolla"},{"name":"Department of Radiation Medicine and Applied Sciences, School of Medicine, University of California San Diego, La Jolla"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borsika A.","family":"Rabin","sequence":"additional","affiliation":[{"name":"Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, La Jolla"},{"name":"UC San Diego Altman Clinical and Translational Research Institute, Dissemination and Implementation Science Center, University of California San Diego, La Jolla"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila F.","family":"Casta\u00f1eda","sequence":"additional","affiliation":[{"name":"Department of Psychology, San Diego State University, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Covin","sequence":"additional","affiliation":[{"name":"Health Quality Partners of Southern California, San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine","family":"Ortwine","sequence":"additional","affiliation":[{"name":"Integrated Health Partners of Southern California, San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yesenia","family":"Preciado-Hidalgo","sequence":"additional","affiliation":[{"name":"Health Quality Partners of Southern California, San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Howard","sequence":"additional","affiliation":[{"name":"Health Quality Partners of Southern California, San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Schultz","sequence":"additional","affiliation":[{"name":"Neighborhood Healthcare, Escondido, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nannette","family":"Stamm","sequence":"additional","affiliation":[{"name":"Vista Community Clinic, Vista, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Halpern","sequence":"additional","affiliation":[{"name":"University of Texas at San Antonio School of Public Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Gupta","sequence":"additional","affiliation":[{"name":"UC San Diego Moores Cancer Center, University of California San Diego, La Jolla"},{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, UC San Diego, La Jolla, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,10,21]]},"reference":[{"key":"zoi261052r1","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2025.118135","article-title":"Racial\/ethnic disparities in all-cause and cause-specific death among patients with colorectal cancer in the United States from 1992 to 2021: a registry-based cohort retrospective analysis.","volume":"377","author":"Qi","year":"2025","journal-title":"Soc Sci Med"},{"issue":"2","key":"zoi261052r2","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3322\/caac.21812","article-title":"American Cancer Society\u2019s report on the status of cancer disparities in the United States, 2023.","volume":"74","author":"Islami","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"13","key":"zoi261052r3","doi-asserted-by":"publisher","first-page":"14767","DOI":"10.1002\/cam4.6105","article-title":"Who, where, when: colorectal cancer disparities by race and ethnicity, subsite, and stage.","volume":"12","author":"Primm","year":"2023","journal-title":"Cancer Med"},{"issue":"14","key":"zoi261052r4","doi-asserted-by":"publisher","first-page":"3636","DOI":"10.1002\/cncr.26677","article-title":"Socioeconomic status and the risk of colorectal cancer: an analysis of more than a half million adults in the National Institutes of Health-AARP Diet and Health Study.","volume":"118","author":"Doubeni","year":"2012","journal-title":"Cancer"},{"issue":"4","key":"zoi261052r6","doi-asserted-by":"publisher","first-page":"587","DOI":"10.2105\/AJPH.2019.305524","article-title":"Outreach and inreach strategies for colorectal cancer screening among Latinos at a federally qualified health center: a randomized controlled trial, 2015-2018.","volume":"110","author":"Casta\u00f1eda","year":"2020","journal-title":"Am J Public Health"},{"issue":"11","key":"zoi261052r7","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1158\/1055-9965.EPI-23-0597","article-title":"Effectiveness and cost of an enhanced mailed fecal test outreach colorectal cancer screening program: findings from the PROMPT stepped-wedge trial.","volume":"32","author":"Coronado","year":"2023","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"9","key":"zoi261052r8","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1001\/jamainternmed.2018.3629","article-title":"Effectiveness of a mailed colorectal cancer screening outreach program in community health clinics: the STOP CRC cluster randomized clinical trial.","volume":"178","author":"Coronado","year":"2018","journal-title":"JAMA Intern Med"},{"issue":"12","key":"zoi261052r9","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1001\/jamainternmed.2018.4637","article-title":"Evaluation of interventions intended to increase colorectal cancer screening rates in the United States: a systematic review and meta-analysis.","volume":"178","author":"Dougherty","year":"2018","journal-title":"JAMA Intern Med"},{"issue":"4","key":"zoi261052r10","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3322\/caac.21615","article-title":"Mailed fecal immunochemical test outreach for colorectal cancer screening: summary of a Centers for Disease Control and Prevention-sponsored summit.","volume":"70","author":"Gupta","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"zoi261052r11","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ypmed.2018.10.021","article-title":"Population health interventions to improve colorectal cancer screening by fecal immunochemical tests: a systematic review.","volume":"118","author":"Issaka","year":"2019","journal-title":"Prev Med"},{"issue":"9","key":"zoi261052r12","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1007\/s10620-019-05587-6","article-title":"Mailed outreach is superior to usual care alone for colorectal cancer screening in the USA: a systematic review and meta-analysis.","volume":"64","author":"Jager","year":"2019","journal-title":"Dig Dis Sci"},{"issue":"11","key":"zoi261052r13","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.46693","article-title":"Centralized colorectal cancer screening outreach in federally qualified health centers: a randomized clinical trial.","volume":"7","author":"Reuland","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"11","key":"zoi261052r14","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1007\/s10552-015-0650-0","article-title":"Two-year follow-up of the effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers.","volume":"26","author":"Baker","year":"2015","journal-title":"Cancer Causes Control"},{"issue":"5 Pt 1","key":"zoi261052r15","doi-asserted-by":"publisher","first-page":"301","DOI":"10.7326\/0003-4819-158-5-201303050-00002","article-title":"An automated intervention with stepped increases in support to increase uptake of colorectal cancer screening: a randomized trial.","volume":"158","author":"Green","year":"2013","journal-title":"Ann Intern Med"},{"key":"zoi261052r16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2023.107353","article-title":"Hub-and-spoke centralized intervention to optimize colorectal cancer screening and follow-up: a pragmatic, cluster-randomized controlled trial protocol.","volume":"134","author":"Casta\u00f1eda","year":"2023","journal-title":"Contemp Clin Trials"},{"issue":"6","key":"zoi261052r18","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1016\/j.cgh.2021.07.022","article-title":"Increased colorectal cancer screening sustained with mailed fecal immunochemical test outreach.","volume":"20","author":"Lee","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"zoi261052r19","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1001\/jama.2017.11389","article-title":"Effect of colonoscopy outreach vs fecal immunochemical test outreach on colorectal cancer screening completion: a randomized clinical trial.","volume":"318","author":"Singal","year":"2017","journal-title":"JAMA"},{"issue":"3","key":"zoi261052r20","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.0928","article-title":"Mailed outreach and patient navigation for colorectal cancer screening among rural Medicaid enrollees: a cluster randomized clinical trial.","volume":"8","author":"Coronado","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"19","key":"zoi261052r22","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1001\/jama.2021.6238","article-title":"Screening for colorectal cancer: US Preventive Services Task Force recommendation statement.","volume":"325","author":"Davidson","year":"2021","journal-title":"JAMA"},{"issue":"8","key":"zoi261052r23","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1158\/1055-9965.EPI-20-0230","article-title":"Challenges and approaches to measuring repeat fecal immunochemical test for colorectal cancer screening.","volume":"29","author":"Murphy","year":"2020","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"zoi261052r24","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/cncr.29734","article-title":"Impact of continued mailed fecal tests in the patient-centered medical home: year 3 of the Systems of Support to Increase Colon Cancer Screening and Follow-Up randomized trial.","volume":"122","author":"Green","year":"2016","journal-title":"Cancer"},{"issue":"18","key":"zoi261052r25","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1002\/cncr.35369","article-title":"A pragmatic randomized trial of mailed fecal immunochemical testing to increase colorectal cancer screening among low-income and minoritized populations.","volume":"130","author":"Mart\u00ednez","year":"2024","journal-title":"Cancer"},{"issue":"8","key":"zoi261052r26","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1093\/jnci\/djaa117","article-title":"The COVID-19 pandemic: identifying adaptive solutions for colorectal cancer screening in underserved communities.","volume":"113","author":"Nodora","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"zoi261052r5","unstructured":"American Cancer Society. Colorectal cancer facts & figures 2023-2025. American Cancer Society. Accessed September 14, 2026. https:\/\/www.cancer.org\/content\/dam\/cancer-org\/research\/cancer-facts-and-statistics\/colorectal-cancer-facts-and-figures\/colorectal-cancer-facts-and-figures-2023.pdf"},{"key":"zoi261052r17","unstructured":"Martinez? E. Colorectal cancer screening for Southern California community health centers. Updated August 26, 2025. Accessed September 4, 2025. https:\/\/clinicaltrials.gov\/study\/NCT04941300"},{"key":"zoi261052r21","unstructured":"Health Resources and Services Administration Bureau of Primary Health Care. Uniform Data system: reporting instructions for calendar year 2020. Accessed August 12, 2025. https:\/\/bphcdata.net\/wp-content\/uploads\/2020\/06\/2020UDSManual.pdf"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2855574\/martinez_2026_oi_261052_1791995794.50429.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:00:44Z","timestamp":1792594844000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2855574"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2026,10,21]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.39013","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,21]]}}}